C4 Therapeutics Inc (NASDAQ:CCCC) shares, rose in value, with the stock price down by -6.23% to the previous day’s close as strong demand from buyers drove the stock to $6.47.
Actively observing the price movement in the last trading, the stock closed the session at $6.90. Referring to stock’s 52-week performance, its high was $11.88, and the low was $1.06. On the whole, CCCC has fluctuated by -21.19% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CCCC’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CCCC currently trading nearly -13.49% and -24.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 32.11, while the 7-day volatility ratio is showing 6.13% which for the 30-day chart, stands at 5.93%. Furthermore, C4 Therapeutics Inc (CCCC)’s beta value is 3.20, and its average true range (ATR) is 0.51.
A comparison of C4 Therapeutics Inc (CCCC) with its peers suggests the former has fared considerably weaker in the market. CCCC showed an intraday change of -6.23% in last session, and over the past year, it grew by 105.40%%.
Data on historical trading for C4 Therapeutics Inc (NASDAQ:CCCC) indicates that the trading volumes over the past 3 months, they’ve averaged 2.64 million. According to company’s latest data on outstanding shares, there are 60.47 million shares outstanding.
Nearly 15.88% of C4 Therapeutics Inc’s shares belong to company insiders and institutional investors own 71.76% of the company’s shares. The stock has risen by 14.51% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CCCC stock heading into the next quarter.
